My more constructive Email to SimonSubject: RE: Shareholders Value
From: #####>
To: #####>,Simon Goulet <#####>
CC:
Simon,
It has been a week since the results were released to the market. I am sure releasing the data in the same way the single dose was done could help ease investors nerves. ALSO, it would be nice to understand next steps in regards to licencing, aNCI or really Current mouse models
THANK YOU